Status:

COMPLETED

Evaluation of the Presence of SENS-401 in the Perilymph

Lead Sponsor:

Sensorion

Conditions:

Hearing Loss

Eligibility:

All Genders

18+ years

Phase:

PHASE2

Brief Summary

The aim of this study is to detect the presence of SENS-401 in the perilymph of participants undergoing cochlear implant surgery after 7 days of oral administration of SENS-401.

Detailed Description

The study is a Phase IIa, open-label, randomized and controlled study investigating repeated twice-daily administration of oral SENS-401 in adult participants with moderately severe to profound hearin...

Eligibility Criteria

Inclusion

  • Main
  • Potential participants must fulfil all of the following main inclusion criteria to be eligible for the study:
  • Adults aged from 18 years and older;
  • Meets the locally approved indication for cochlear implantation. The individual must have freely consented to the cochlear implant surgery before being offered to participate in the SENS-401-203 study;
  • Signed and dated written informed consent;
  • Main

Exclusion

  • Individuals will be excluded from the study if any of the following main exclusion criteria apply:
  • Moderate to severe renal impairment defined by a creatinine clearance ≤ 60 ml/min
  • Any condition that, in the opinion of the Investigator, may compromise the safety or compliance of the participant or would preclude the participant from successful completion of the study
  • Unable or unwilling to comply with the protocol requirements
  • Known hypersensitivity, allergy or intolerance to the study medication or any history of severe abnormal drug reaction

Key Trial Info

Start Date :

August 10 2022

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

May 31 2024

Estimated Enrollment :

28 Patients enrolled

Trial Details

Trial ID

NCT05258773

Start Date

August 10 2022

End Date

May 31 2024

Last Update

April 23 2025

Active Locations (7)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 2 (7 locations)

1

Royal Victorian Eye and Ear Hospital

Melbourne, Australia

2

Centre Hospitalier Universitaire de Bordeaux, Hôpital Pellegrin

Bordeaux, France

3

Centre Hospitalier Universitaire de Clermont-Ferrand - Hôpital Gabriel Montpied

Clermont-Ferrand, France

4

Centre Hospitalier Universitaire de Lille Hôpital Roger Salengro

Lille, France